MK-677 'results' videos: what the gym crowd isn't telling you
Quick answer
MK-677 (ibutamoren) is an investigational oral ghrelin receptor agonist that stimulates endogenous GH secretion and raises IGF-1 levels by 40-90% above baseline in clinical studies, with documented effects on lean mass and sleep architecture. Trials have also identified meaningful metabolic concerns including elevated fasting glucose and insulin resistance, particularly with extended use at 25mg daily. It remains unapproved by the FDA and is prohibited by WADA.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What's this video probably claiming?
A gym-focused TikTok captioned 'results of MK677' with a grimacing emoji almost certainly follows a familiar format: before-and-after physique shots, claims about muscle gain or fat loss, and implicit or explicit attribution of those changes to MK-677 (ibutamoren). The hashtags point squarely at a bodybuilding audience, which means the framing is probably something like 'I took MK-677 for X weeks and here's what happened to my body.' There may also be commentary on sleep quality, hunger levels, or 'GH pulse' effects, which are the talking points that circulate in fitness communities. What these videos rarely include: dosing transparency, disclosure of concurrent training protocols, diet changes, other compounds being used simultaneously, or any acknowledgment that MK-677 is an unapproved investigational drug with a real side effect profile. The grimacing emoji might signal side effects, which would actually be more honest than most.
What does the science actually show?
MK-677 is a ghrelin mimetic and growth hormone secretagogue, not a peptide in the traditional sense. It orally stimulates GH release by binding the ghrelin receptor. The clinical data exists, and it's genuinely interesting, but it does not support the bodybuilding fantasy version of this compound. Nass et al. (2008, Annals of Internal Medicine) found that two years of MK-677 at 25mg daily in older adults increased lean mass by about 1.6kg and reduced fat mass modestly, but also increased fasting glucose and insulin resistance in a meaningful subset of participants. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed GH pulse amplification in healthy adults at doses of 10-50mg, but also documented water retention and significant appetite stimulation. IGF-1 elevations are real, typically 40-90% above baseline depending on dose, but sustained supraphysiologic IGF-1 carries theoretical cancer-promotion concerns that no gym TikToker will mention.
Where does the social media noise diverge from clinical reality?
The gap between the TikTok version of MK-677 and what the studies show is substantial. First, gym creators routinely attribute physique changes solely to MK-677 while simultaneously being in a caloric surplus, running progressive overload programs, and sometimes stacking anabolic compounds they don't disclose. Attributing results to one variable in that context is not science, it's content. Second, the 'sleep improvement' claim is real but context-dependent. Chapman et al. (1996, Sleep) documented increased REM and slow-wave sleep in elderly men, but the effect in young, trained athletes is not well established. Third, the water retention that bloats faces and waists during MK-677 use is almost never contextualized as the mechanism behind rapid scale weight changes. Finally, nobody in these videos talks about the insulin resistance signal from the Nass 2008 trial, because it would complicate the narrative significantly.
What should you actually know?
MK-677 is not approved by the FDA for any indication. It is not a peptide, it is a small molecule drug that happens to work through a peptide receptor. The World Anti-Doping Agency (WADA) prohibits it. It has been investigated for muscle wasting, frailty, and growth hormone deficiency, but none of those trials have resulted in an approved drug. The appetite stimulation is real and clinically significant: users routinely report hunger levels that make body recomposition extremely difficult without disciplined caloric control, which most viral 'results' videos don't address. If you are seeing a regulated telehealth provider and MK-677 is part of a medically supervised protocol, that is a different context from buying research chemicals and dosing based on TikTok comments. These are not the same thing, and anyone blurring that line is doing you a disservice. Side effects including edema, elevated fasting glucose, and joint pain from water retention are underreported in fitness content.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 'results' videos: what the gym crowd isn't telling you, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 'results' videos: what the gym crowd isn't telling you is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
MK-677 (ibutamoren) is an investigational oral ghrelin receptor agonist that stimulates endogenous GH secretion and raises IGF-1 levels by 40-90% above baseline in clinical studies, with documented effects on lean mass and sleep architecture.
FormBlends verdict
MK-677 (ibutamoren) is an investigational oral ghrelin receptor agonist that stimulates endogenous GH secretion and raises IGF-1 levels by 40-90% above baseline in clinical studies, with documented effects on lean mass and sleep architecture. Trials have also identified meaningful metabolic concerns including elevated fasting glucose and insulin resistance, particularly with extended use at 25mg daily. It remains unapproved by the FDA and is prohibited by WADA.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an investigational oral ghrelin receptor agonist that stimulates endogenous GH secretion and raises IGF-1 levels by 40-90% above baseline in clinical studies, with documented effects on lean mass and sleep architecture. Trials have also identified meaningful metabolic concerns including elevated fasting glucose and insulin resistance, particularly with extended use at 25mg daily. It remains unapproved by the FDA and is prohibited by WADA.
- MK-677 is an investigational oral drug, not an approved medication, and is prohibited by WADA in competitive sport.
- Clinical trials show IGF-1 elevations of 40-90% above baseline, but lean mass gains in controlled studies are modest, roughly 1.6kg over two years in older adults.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- MK-677 is an investigational oral drug, not an approved medication, and is prohibited by WADA in competitive sport.
- Clinical trials show IGF-1 elevations of 40-90% above baseline, but lean mass gains in controlled studies are modest, roughly 1.6kg over two years in older adults.
- Nass et al. (2008) found elevated fasting glucose and insulin resistance in participants using 25mg daily for two years, a risk almost never discussed in gym content.
- Rapid weight changes on MK-677 are substantially driven by water retention, not muscle accrual, and scale weight is not a reliable outcome measure for this compound.
- Sleep architecture improvements are documented in elderly populations but have not been adequately studied in young trained athletes.
- Attributing physique results solely to MK-677 without disclosing full diet, training, and other compounds is not scientifically meaningful and should be treated with significant skepticism.
- Medical supervision that includes fasting glucose monitoring is not optional if MK-677 is being used as part of a legitimate protocol.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
🇵🇰حارث خان · TikTok creator
256.0K views on this video
results of MK677 😬 #gym #GymLife #gymrat #fyppp
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by 🇵🇰حارث خان, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.